KEAP1 and non-small cell lung carcinoma: Clinical studies consistently demonstrate inferior outcomes with ICIs in <i>STK11</i>-mutant NSCLC, particularly in the presence of <i>KRAS</i> and <i>KEAP1</i> co-mutations.